This Educational Meeting will review the evolving challenges in the field of CM
risk management, with specific focus on the current thinking regarding the drivers
and pathological process underlying CM risk. Keys concepts for patient evaluation
and classification will be explored, and the importance of lifestyle changes to
the management of cardiometabolic risk will be reinforced.
In addition, specific recommendations regarding the use of novel medical strategies
in the management of cardiometabolic risk will be detailed. These recommendations
are designed to supplement, not replace, treatment protocols currently utilized
at lipid clinics.
Finally, practical aspects regarding program implementation will be discussed, and
a number of clinician tools will be provided to aid in the adoption of program recommendations
into clinical practice.
Evolving Challenges in Cardiometabolic Risk Management
- – Epidemic of overweight/obesity and diabetes
- – Residual risk remaining with current treatment approaches
The Drivers of Cardiometabolic Risk
- – Link between central adiposity and cardiometabolic risk
- – Mechanisms underlying negative cardiometabolic effects
Patient Evaluation and Classification
- – Basics of office-based obesity care
- – Keys to assessing cardiometabolic risk
Treating the Overweight/Obese Patient – Medical Considerations
- – Assessment of medications that may contribute to cardiometabolic risk
- – Pharmacotherapy options for weight loss and enhanced risk management
- Patient Management
- – Managing risk with diet and exercise
- – Tips for effective patient referral, clinical monitoring, and follow-up
Treatment program – Implementation
- – Practical approaches to program implementation
- – Roles for healthcare team members
Case Studies
- – 2 case studies to help attendees apply the program recommendations in their practice
- – Specific processes for patient identification and follow-up
Accreditation
This CME activity is sponsored by the National Lipid Association.
